Boehinger Ingleheim

Random entry RSS

Posted in:
News

Boehringer Ingelheim Prevails in IPR Against AbbVie’s ’135 Humira Patent
By C. Nichole Gifford July 17, 2017 Comments are off
Boehringer Ingelheim International GMBH and Boehringer Ingelheim Pharmaceuticals, Inc. (“Boehringer Ingelheim”) have prevailed in two...

Read more

Tagged with: AbbVie, adalimumab, Amgen, Boehinger Ingleheim, Coherus, Humira®, Legal, News, PTAB

http://twitter.com/share?text="[TITLE]&url=[PERMALINK]
ShareEmail, Linked In, Twitter, Facebook, Google Plus

Back to Top